TRANSCRIPTIONAL PHARMACOLOGY OF NEURODEGENERATIVE DISORDERS - NOVEL VENUE TOWARDS NEUROPROTECTION AGAINST EXCITOTOXICITY

Authors
GRILLI M MEMO M
Citation
M. Grilli et M. Memo, TRANSCRIPTIONAL PHARMACOLOGY OF NEURODEGENERATIVE DISORDERS - NOVEL VENUE TOWARDS NEUROPROTECTION AGAINST EXCITOTOXICITY, Molecular psychiatry, 2(3), 1997, pp. 192-194
Citations number
15
Categorie Soggetti
Psychiatry,Biology
Journal title
Molecular psychiatry → ACNP
ISSN journal
13594184
Volume
2
Issue
3
Year of publication
1997
Pages
192 - 194
Database
ISI
SICI code
1359-4184(1997)2:3<192:TPOND->2.0.ZU;2-I
Abstract
Transcription factors NF-kappa B/Rel represent the point of convergenc e of several signalling pathways relevant to neurodegeneration. The fi nding that salicylates elicit neuroprotection via blockade of NF-kappa B provides new opportunities for pharmacological intervention.